Provided by Tiger Trade Technology Pte. Ltd.

Gossamer Bio Inc.

2.35
+0.02000.86%
Post-market: 2.32-0.0300-1.28%19:42 EST
Volume:5.44M
Turnover:12.56M
Market Cap:543.92M
PE:-3.42
High:2.38
Open:2.33
Low:2.24
Close:2.33
52wk High:3.87
52wk Low:0.7600
Shares:231.46M
Float Shares:183.82M
Volume Ratio:0.84
T/O Rate:2.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6874
EPS(LYR):-0.2499
ROE:-783.37%
ROA:-34.25%
PB:-6.61
PE(LYR):-9.40

Loading ...

Gossamer Bio (GOSS) Receives a Buy from Barclays

TIPRANKS
·
Feb 10

Gossamer Bio Initiated at Overweight by Barclays

Dow Jones
·
Jan 28

Barclays Initiates Coverage on Gossamer Bio With Overweight Rating, $9 Price Target

MT Newswires Live
·
Jan 28

Gossamer Bio Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
Jan 22

Gossamer Bio Grants Stock Options to New Employees Under 2023 Inducement Plan

Reuters
·
Jan 09

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jan 09

Gossamer Bio Currently Down Eight Consecutive Days, on Pace for Longest Losing Streak Since November 2024 -- Data Talk

Dow Jones
·
Jan 08

BRIEF-Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Dec 10, 2025

Gossamer Bio Grants Stock Options to New Employee Under Inducement Plan

Reuters
·
Dec 10, 2025

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Nov 20, 2025

Stock Track | Gossamer Bio Soars 5.30% Pre-Market as Oppenheimer Raises Price Target

Stock Track
·
Nov 10, 2025

BRIEF-Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Nov 08, 2025

Gossamer Bio Grants Stock Options to New Employees Under 2023 Inducement Plan

Reuters
·
Nov 08, 2025

Gossamer Bio Inc. to Present at Guggenheim Securities Healthcare Innovation Conference

Reuters
·
Nov 07, 2025

Gossamer Bio's Q3 net loss widens to $48.2 mln

Reuters
·
Nov 06, 2025

BRIEF-Gossamer Bio Q3 EPS USD -0.21

Reuters
·
Nov 06, 2025

Gossamer Bio Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
Nov 04, 2025

EXPLAINER-How companies are steering IPO plans amid US government shutdown

Reuters
·
Oct 07, 2025

Wedbush Adjusts Gossamer Bio Price Target to $6 From $5, Maintains Outperform Rating

MT Newswires Live
·
Sep 25, 2025

Sector Update: Health Care Stocks Decline Premarket Thursday

MT Newswires Live
·
Sep 25, 2025